592 related articles for article (PubMed ID: 15878737)
21. STAT1 is involved in signal transduction in the EPO induced HEL cells.
Chu J; Gui CY; Fan J; Tang XD; Qiao RL
Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
[TBL] [Abstract][Full Text] [Related]
22. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
Bulut GB; Sulahian R; Yao H; Huang LJ
Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
[TBL] [Abstract][Full Text] [Related]
23. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
[TBL] [Abstract][Full Text] [Related]
24. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
25. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
Sawyer ST; Penta K
J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
[TBL] [Abstract][Full Text] [Related]
26. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.
Chin H; Nakamura N; Kamiyama R; Miyasaka N; Ihle JN; Miura O
Blood; 1996 Dec; 88(12):4415-25. PubMed ID: 8977232
[TBL] [Abstract][Full Text] [Related]
27. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
[TBL] [Abstract][Full Text] [Related]
29. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
[TBL] [Abstract][Full Text] [Related]
30. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
Fan H; Kanji S; Zhai M
Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
32. Genetic heterogeneity of primary familial and congenital polycythemia.
Kralovics R; Prchal JT
Am J Hematol; 2001 Oct; 68(2):115-21. PubMed ID: 11559951
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.
Quelle FW; Wang D; Nosaka T; Thierfelder WE; Stravopodis D; Weinstein Y; Ihle JN
Mol Cell Biol; 1996 Apr; 16(4):1622-31. PubMed ID: 8657137
[TBL] [Abstract][Full Text] [Related]
34. "Benign erythrocytosis" and other familial and congenital polycythemias.
Prchal JT; Sokol L
Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
36. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor.
Furukawa T; Narita M; Sakaue M; Otsuka T; Kuroha T; Masuko M; Azegami T; Kishi K; Takahashi M; Utsumi J; Koike T; Aizawa Y
Br J Haematol; 1997 Oct; 99(1):222-7. PubMed ID: 9359528
[TBL] [Abstract][Full Text] [Related]
37. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.
Kirito K; Nakajima K; Watanabe T; Uchida M; Tanaka M; Ozawa K; Komatsu N
Blood; 2002 Jan; 99(1):102-10. PubMed ID: 11756159
[TBL] [Abstract][Full Text] [Related]
38. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
[TBL] [Abstract][Full Text] [Related]
39. The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.
Harris KW; Hu XJ; Schultz S; Arcasoy MO; Forget BG; Clare N
Blood; 1998 Aug; 92(4):1219-24. PubMed ID: 9694710
[TBL] [Abstract][Full Text] [Related]
40. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
Ueda F; Tago K; Tamura H; Funakoshi-Tago M
J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]